Central Nervous System Diseases: all 386 studies
Page 4 of 4. Open to participants first (104), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's DiseaseCompletedNCT03065192Phase 1
- The SaeboGlove Evaluation TrialStatus unknownNCT03036033Not applicable
- Novel Brain Stimulation Therapies in Stroke Guided Expressions of PlasticityCompletedNCT03020433Early Phase 1
- Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of ConsciousnessCompletedNCT03008486Phase 2
- Intelligent Activity-based Client-centred TrainingCompletedNCT02982811Not applicable
- Individualized Prediction of Migraine Attacks Using a Mobile Phone App and FitbitCompletedNCT02910921
- ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)CompletedNCT02880878Not applicable
- Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIMTerminatedNCT02823158Not applicable
- Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic InflammationCompletedNCT02794857Phase 2
- F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)WithdrawnNCT02707978Phase 2
- Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)Active, not recruitingNCT02696603Not applicable
- Detection of Silent Atrial Fibrillation aFter Ischemic StrOkeCompletedNCT02684825Not applicable
- Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant EpilepsyApproved for marketingNCT02660255
- General Anesthesia for Endovascular Thrombectomy; A Pilot Study.CompletedNCT02639806
- Reliability of the Melbourne AssessmentCompletedNCT02595411
- MS Symptom Management StudyCompletedNCT02474940Not applicable
- In Vivo Imaging of Therapeutic Electric Current FlowCompletedNCT02453763
- A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure DetectionCompletedNCT02431780Not applicable
- F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)CompletedNCT02414282
- REperfusion With Cooling in CerebraL Acute IscheMia IIWithdrawnNCT02411877Phase 2
- Feasibility of the Portable YouGrabber SystemCompletedNCT02368223Not applicable
- Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With EncephalitisCompletedNCT02308982Phase 3
- Retrospective Study of MRI in Pediatric PatientsCompletedNCT02291822
- MyndMove Therapy for Severe Hemiparesis of the Upper Limb Following StrokeCompletedNCT02266836Not applicable
- Improving Cognitive Aptitudes With tDCS in Patients With Multiple SclerosisTerminatedNCT02266121Not applicable
- Gamma Knife Radiosurgery for Treatment of Essential TremorStatus unknownNCT02255929Not applicable
- DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain TumorsCompletedNCT02197169Phase 1
- RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic StrokeStatus unknownNCT02129920
- Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm NeonatesStatus unknownNCT02050971Phase 1
- The Role of Primary Motor Cortex and Prefrontal Cortex for Facilitation of Motor System and Working MemoryStatus unknownNCT02006615Not applicable
- Natural History Study of Children With Metachromatic LeukodystrophyTerminatedNCT01963650
- A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's DiseaseCompletedNCT01928420Phase 2
- Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)WithdrawnNCT01923376Not applicable
- Determining Optimal Post-Stroke Exercise (DOSE)CompletedNCT01915368Not applicable
- Observational Study of Ischaemic StrokeCompletedNCT01859572
- GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)CompletedNCT01854294Phase 2
- Vascular Risk Factors in INPH-patientsCompletedNCT01850914
- Short Effects of a Rehabilitation Session on Gait in Patients With CNSCompletedNCT01807247
- Risk Factors in the Initial Presentation of Specific Cardiovascular Disease SyndromesCompletedNCT01804439
- Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral SclerosisCompletedNCT01758510Phase 1
- STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia TrialCompletedNCT01702636Phase 2
- The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-ADStatus unknownNCT01696591
- International Subarachnoid Aneurysm Trial IIActive, not recruitingNCT01668563Not applicable
- Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's DiseaseCompletedNCT01662414Phase 4
- Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain InjuryWithdrawnNCT01605357Phase 1/2
- Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in ChildrenStatus unknownNCT01593488Phase 2
- Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's DiseaseCompletedNCT01539031Phase 3
- The Natural History of Procalcitonin in Hemorrhagic StrokeWithdrawnNCT01498705
- A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) BiomarkersCompletedNCT01495390
- A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington DiseaseCompletedNCT01485965Phase 1
- An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196CompletedNCT01485952Phase 1
- Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic StrokeCompletedNCT01468064Phase 1/2
- Dexmedetomidine in Patients After Intracranial SurgeryCompletedNCT01445639Phase 4
- A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's DiseaseCompletedNCT01404169Phase 3
- Influence of Physical Exercise on Cognitive Functioning of Traumatic Brain Injury PatientsStatus unknownNCT01395472Not applicable
- An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.CompletedNCT01386580Phase 1/2
- Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in ChinaCompletedNCT01340950Phase 4
- Phase II BGG492 Capsule Extension for Partial EpilepsyCompletedNCT01338805Phase 2
- Endothelial Function and Progenitor Cells in Acute Ischemic StrokeStatus unknownNCT01289795
- Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype CorrelationCompletedNCT01272687
- ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care UnitCompletedNCT01270269Not applicable
- Internet-based Interacting Together Everyday, Recovery After Childhood TBI (I-InTERACT)--RRTCCompletedNCT01214694Not applicable
- Caffeine for Motor Manifestations of Parkinson's DiseaseCompletedNCT01190735Phase 2
- TMS Stimulation and Cognitive Training in Alzheimer PatientsCompletedNCT01168245Phase 1
- Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset SeizuresWithdrawnNCT01167335Phase 2
- Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer PatientsCompletedNCT01097096Phase 2
- Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT01073228Phase 2
- Interacting Together Everyday: Recovery After Childhood Traumatic Brain Injury (TBI) "I-InTERACTCompletedNCT01056146Not applicable
- To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsCompletedNCT01023685Phase 2
- Safety and Cognitive Function Study of EVP-6124 in Patients With SchizophreniaCompletedNCT00968851Phase 2
- To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsCompletedNCT00956410Phase 2
- Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed GlioblastomaTerminatedNCT00895960Phase 1
- DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant GliomasCompletedNCT00805376Phase 1
- Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's PatientsCompletedNCT00795418Phase 2
- Clinical Evaluation of Swallowing Disorders as a Predictor of Extubation FailureCompletedNCT00780078
- Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.CompletedNCT00733863Phase 2
- A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain MetastasesCompletedNCT00649207Phase 1
- Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's DiseaseTerminatedNCT00643890Phase 2
- Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes DatabaseCompletedNCT00593411
- Influence of Area of Brain Damage on Brain Reorganization After Chronic StrokeCompletedNCT00474292
- Central Nervous System Disease in HIV-infected Children on HAARTCompletedNCT00110331
- Brain Processing of Language MeaningsCompletedNCT00005004
- A Study of Azidothymidine in HIV-Infected ChildrenCompletedNCT00000982Phase 2
- A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS PatientsCompletedNCT00000945Not applicable
- Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical TrialsCompletedNCT00000759
- Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1CompletedNCT00000738Phase 1